糖尿病患者使用药物洗脱支架的经皮冠状动脉介入治疗 - Suppr

Suppr

超能文献

Percutaneous coronary interventions with drug eluting stents for diabetic patients.

作者信息

Seabra-Gomes Ricardo

机构信息

Instituto do Coração, Lisbon, Portugal.

出版信息

Heart. 2006 Mar;92(3):410-9. doi: 10.1136/hrt.2005.062992.

DOI:10.1136/hrt.2005.062992

PMID:16501210

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1860831/

Abstract

摘要

相似文献

Percutaneous coronary interventions with drug eluting stents for diabetic patients.

Heart. 2006 Mar;92(3):410-9. doi: 10.1136/hrt.2005.062992.

Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome.

J Thorac Cardiovasc Surg. 2006 May;131(5):956-62. doi: 10.1016/j.jtcvs.2005.10.058. Epub 2006 Apr 27.

One-year clinical results and total costs of drug-eluting stents implantation in multivessel coronary artery disease.

J Cardiovasc Med (Hagerstown). 2007 Aug;8(8):596-601. doi: 10.2459/JCM.0b013e32801051f4.

Optimal revascularization strategy for diabetic patients with multivessel coronary artery disease: the duel between old hero and young warrior.

Int J Cardiol. 2009 Jan 9;131(2):269-70; author reply 271-2. doi: 10.1016/j.ijcard.2007.05.103. Epub 2007 Aug 10.

Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.

Circulation. 2007 Sep 11;116(11 Suppl):I200-6. doi: 10.1161/CIRCULATIONAHA.106.681148.

Revascularisation strategy for diabetic multivessel coronary arteriopathy.

J Indian Med Assoc. 2006 Apr;104(4):186, 188-9, 194.

Drug-eluting stents or drug-eluting conduits for multivessel disease?

J Cardiovasc Med (Hagerstown). 2007 May;8(5):359-61. doi: 10.2459/JCM.0b013e32807fb060.

Revascularization of unprotected left main coronary artery disease with percutaneous coronary intervention: the role of drug-eluting stents.

Minerva Cardioangiol. 2008 Feb;56(1):43-53.

Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.

J Am Coll Cardiol. 2008 Dec 9;52(24):1957-67. doi: 10.1016/j.jacc.2008.09.010.

Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.

J Am Coll Cardiol. 2006 Jul 18;48(2):262-7. doi: 10.1016/j.jacc.2006.01.080. Epub 2006 Jun 22.

引用本文的文献

Association of plasma endothelin-1 levels with revascularization strategies and short-term clinical outcomes: Role of diabetes.

Heliyon. 2024 Sep 11;10(18):e37777. doi: 10.1016/j.heliyon.2024.e37777. eCollection 2024 Sep 30.

Biofunctionalization of cardiovascular stents to induce endothelialization: Implications for in- stent thrombosis in diabetes.

Front Pharmacol. 2022 Oct 10;13:982185. doi: 10.3389/fphar.2022.982185. eCollection 2022.

Percutaneous coronary intervention in insulin-treated diabetic patients: A meta-analysis.

Ann Noninvasive Electrocardiol. 2022 Sep;27(5):e12953. doi: 10.1111/anec.12953. Epub 2022 Apr 25.

Some Perspectives on Hypersensitivity to Coronary Stents.

Int J Gen Med. 2021 Aug 10;14:4327-4336. doi: 10.2147/IJGM.S326679. eCollection 2021.

Long-term outcomes of medical therapy versus successful recanalisation for coronary chronic total occlusions in patients with and without type 2 diabetes mellitus.

Cardiovasc Diabetol. 2020 Jul 4;19(1):100. doi: 10.1186/s12933-020-01087-4.

In-Hospital Outcome of Patients with Diabetes Mellitus after CTO Recanalization with Third-Generation Drug-Eluting Stents.

J Tehran Heart Cent. 2019 Apr;14(2):47-52.

Liraglutide Inhibits Endothelial-to-Mesenchymal Transition and Attenuates Neointima Formation after Endovascular Injury in Streptozotocin-Induced Diabetic Mice.

Cells. 2019 Jun 14;8(6):589. doi: 10.3390/cells8060589.

Comparison of clinical outcomes after drug-eluting stent implantation in diabetic versus nondiabetic patients in China: A retrospective study.

Medicine (Baltimore). 2017 Apr;96(17):e6647. doi: 10.1097/MD.0000000000006647.

Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.

J Mater Sci Mater Med. 2015 Oct;26(10):251. doi: 10.1007/s10856-015-5585-1. Epub 2015 Oct 5.

Favorable Outcomes after Implantation of Biodegradable Polymer Coated Sirolimus-Eluting Stents in Diabetic Population: Results from INDOLIMUS-G Diabetic Registry.

Int J Vasc Med. 2015;2015:265670. doi: 10.1155/2015/265670. Epub 2015 Sep 2.

本文引用的文献

Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.

Circulation. 2005 Oct 4;112(14):2175-83. doi: 10.1161/CIRCULATIONAHA.105.562421.

Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials.

JAMA. 2005 Aug 17;294(7):819-25. doi: 10.1001/jama.294.7.819.

Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.

N Engl J Med. 2005 Aug 18;353(7):663-70. doi: 10.1056/NEJMoa044372. Epub 2005 Aug 16.

Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial.

J Am Coll Cardiol. 2005 Aug 16;46(4):575-81. doi: 10.1016/j.jacc.2004.12.082.

Comparison of short- (one month) and long- (twelve months) term outcomes of sirolimus- versus paclitaxel-eluting stents in 293 consecutive patients with diabetes mellitus (from the RESEARCH and T-SEARCH registries).

Am J Cardiol. 2005 Aug 1;96(3):358-62. doi: 10.1016/j.amjcard.2005.03.075.

Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison.

Circulation. 2005 Jun 28;111(25):3435-42. doi: 10.1161/CIRCULATIONAHA.104.513952. Epub 2005 Jun 20.

Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study.

Circulation. 2005 May 17;111(19):2525-31. doi: 10.1161/01.CIR.0000165072.01672.21. Epub 2005 May 9.

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.

JAMA. 2005 May 4;293(17):2126-30. doi: 10.1001/jama.293.17.2126.

Molecular basis of restenosis and drug-eluting stents.

Circulation. 2005 May 3;111(17):2257-73. doi: 10.1161/01.CIR.0000163587.36485.A7.

Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus.

Circulation. 2005 May 10;111(18):2291-8. doi: 10.1161/01.CIR.0000164232.62768.51. Epub 2005 Apr 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验